John Farahi

CEO John Farahi sold 5,000 shares of MCRI at $120.84 on 2026-05-28; his prior 2 MCRI sales both achieved negative 90-day returns

John Farahi sold 5,000 shares (0.8% of pre-transaction holdings) at $120.84, reducing his stake from 621.6K to 616.6K shares. His prior trade history at MCRI shows a consistent pattern: both of his two previous sales at this ticker produced negative 90-day returns (-10.2% on 2025-12-17 and -0.9% on 2025-08-26), suggesting timing success in executing sales before subsequent declines. The current stock price of $120.26 is within 1.6% of the 52-week high of $122.25, and the 90-day momentum has been strong at +25.1%, though this sale follows a period of appreciation. At a P/E of 19.55 and revenue growth of +4.4%, the company shows stable fundamentals; however, the recurring pattern of well-timed exits by the CEO warrants attention as a potential signal of near-term headwinds.

CEO Farahi sells 6,000 shares (6.0K) for $619,480 across two transactions; stock down 14.1% from 52-week high.

CEO John Farahi sold 6,000 shares totaling $619,480.00 in two separate transactions: 5,000 shares at $103.77 on 2025-08-26 and 1,000 shares at $100.63 on 2025-12-17, with a blended average price of $103.25. This represents a -0.2% reduction in his holdings from 2,527,415 shares to 2,521,415 shares, a modest portfolio adjustment. The current stock price of $92.97 is -14.1% from the 52-week high of $108.21, suggesting the CEO sold above recent lows but below the year's peak. Monarch operates with solid fundamentals including $142.8M quarterly revenue, $31.6M net income, and a P/E of 20.52, though the 30-day and 90-day price declines of -4.4% and -3.9% respectively indicate recent market pressure that preceded or accompanied these sales.